profile

Floris from Blossom

The Bloom 140 - Psychedelics Design Conference

Published 3 months ago • 3 min read

The Bloom #140

Free Edition

let's get creative

Research has been a bit slower in the last week(s), but that has given me more time to present a few updates on Blossom to you.

Starting with 10+ new events being added to the Events database. Find all (big) psychedelic conferences in one place. Ranging from online conferences (e.g. Psychedelics Design, where I will be speaking & moderating) to international scientific gatherings (e.g. ICPR and Horizons).

I've also started updating the overview pages, starting with the Smoking page (which, alas, hasn't needed much updating for such a pivotal topic).

Please let me know in a reply if you're especially interested in seeing a topic page updated or created.

Floris - Founder of Blossom

ps I'm excited to invite you to the Psychedelics Design Conference on April 11, 2024. Psychedelics Design and Blossom created a half-day Online Conference featuring well-known experts such as Paul Austin, Michel Rojkind, Jemma Campbell, and yours truly. Join us to explore the cultural nuances that shape our creative and psychedelic landscapes. Tickets are priced at £20 / $25 and available here. Use code Floris15 for a 15% discount.

Latest Psychedelic Research

1 The antidepressant effects of vaporized N,N-Dimethyltryptamine: a preliminary report in treatment-resistant depression

This open-label Phase IIa clinical trial (n=6) examines the efficacy of vaporized DMT in treating treatment-resistant depression (TRD). Patients experienced significant reductions in two depression scores (MADRS & PHQ-9), with 83% responding to treatment by day 7 and 66.67% achieving remission. The rapid onset and sustained antidepressant effects of vaporized DMT suggest its potential as a practical and accessible option in psychedelic treatments for depression within interventional psychiatry.

Related: Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial

Unlock 2000+ Psychedelic Research Summaries with a Pro Membership

Discover a treasure trove of knowledge and support the vital coverage & advancement of psychedelic research

2 Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins

This review (2023) assesses the potential long-term impact of microdosing psychedelics on cardiac health, particularly focusing on LSD and psilocybin. Despite the increasing popularity of microdosing, concerns arise due to structural similarities between these substances and medications associated with cardiac fibrosis and valvulopathy. The review emphasizes the need for future studies to evaluate the safety of prolonged microdosing and discusses the relationship between drug-induced cardiac fibrosis and the 5-HT2B receptor.

3 Coming back together: A qualitative survey study of coping and support strategies used by people to cope with extended difficulties after the use of psychedelic drugs

This qualitative study (n=608) investigated coping strategies employed by individuals experiencing difficulties persisting for at least one day after a psychedelic experience. Predominant individual coping strategies included meditation and prayer, along with self-educational activities like reading and journaling. Social coping methods were commonly seeking support from friends or family, and obtaining assistance from a therapist or coach, with reported benefits including feeling heard, accepted, and sharing similar experiences.

More new research

New on Blossom

1 Blossom Pro: Research Briefing #4 – Microdosing Risks, Managing Challenging Experiences, and DMT for TRD

The risks of microdosing, challenging experience of psychedelics, and the promise of short-lasting DMT for TRD.

Gain Unparalleled Insight with Pro
Access 2000+ Research Summaries

"Truly useful" - Chris Timmermann

2 Ps​ychedelics & Smoking (Updated)

Smoking is a serious public health threat. Thankfully, psychedelics are promising to help people kick the habit for good.

3 Psychedelic Research Links 2024

All the other papers that have come out this year that don't have a separate entry in the database.

Spotlight

1 Psychedelics Design Conference (Event)

I'm excited to invite you to the ​Psychedelics Design Conference​ on April 11, 2024. Psychedelics Design and Blossom created a half-day Online Conference featuring well-known experts such as Paul Austin, Michel Rojkind, Jemma Campbell, and yours truly. Join us to explore the cultural nuances that shape our creative and psychedelic landscapes. Tickets are priced at £20 / $25 and ​available here​. Use code Floris15 for a 15% discount.

2 MDMA/psychedelics in romantic relationships (Study)

Are you planning to take MDMA, a psychedelic drug/attend a psychedelic retreat with your romantic partner and want to help psychedelic research?

Imperial College London is now investigating the long-term effects of taking psychedelics, MDMA, ketamine, 2C-B, etc. in romantic couples, from intimacy to attachment styles and sexual satisfaction. Click here to know more and sign up:

https://survey.alchemer.eu/s3/90617328/Psychedelics-and-Couples-Sign-up

This study is for people in a romantic relationship, however you can also participate by yourself if your partner do not want to participate. One couple member must enrol in the study first before receiving a unique link to share the study with their partner. You will be asked to select the date of your experience, and you will receive questionnaires at 5 different time points.

Molenvaart 76, Anna Paulowna, NH 1761AL
Unsubscribe · Preferences

Floris from Blossom

I write about the science and implementation of psychedelics as medicines. Join to learn alongside me and make the future happen sooner!

Read more from Floris from Blossom

The Bloom #148 Free Edition rolling Over the last week, it seems that psychedelic research is coming at us faster than ever before. Researchers re-analysed data from a single-blind study of psilocybin-assisted therapy for depression and found that psychological flexibility, mindfulness, and living according to one’s values improved, even four months after the study's conclusion. Next to academic research, I'm seeing an uptick in publications from the psychedelic drug developers, including a...

5 days ago • 2 min read

The Bloom #147 Free Edition the EMA workshop Editor note: My apologies for not getting this email to you last week, I see that it accidentally was stuck in draft - so you are getting this email and the one for this week just a few minutes apart How do psychedelics work? Some may say we have all the answers already, and that all the research currently happening is just an exercise in writing down wisdom that's already present in the wider world outside of academia. Others, notably the...

5 days ago • 3 min read

The Bloom #146 Free Edition open design The psychedelic conference season is just around the corner. I've just updated our Events page, which should now give a good overview of a variety of conferences that are happening in the coming 1.5 years. In-person conferences include ICPR, which has just added a policy-focused day (Pathways of Access Summit) at the start of the conference; with the code BLOSSOM50, you can get a €50 discount. Online you can also bump into me at the Psychedelics and...

21 days ago • 3 min read
Share this post